BioSpace News Archive

Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today it has been awarded the 2nd phase funding from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to continue the development of its antibiotic program Debio 1453, leading to a novel FabI inhibitor drug candidate specifically targeting Neisseria gonorrhoeae

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that is has established a new Scientific Advisory Board (SAB)

Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., today announced that it will hold a conference call on Wednesday, November 20, 2019 at 8:00 AM Eastern Time following the release of its third quarter 2019 financial results.

Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for clascoterone cream 1%.

Akoya Biosciences, Inc., The Spatial Biology Company™, announced that it has launched two new multiplex immunofluorescence kits, expanding its portfolio of solutions for profiling immuno-oncology biomarkers in the tumor microenvironment.

HealthGrowth Capital, LLC, a leading lender and strategic consultant to independent pharmacies, is pleased to announce the appointment of Todd C. Ebert to the Company’s Board of Advisors, effective immediately.

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, presented Inmaculada Hernandez, Pharm.D., Ph.D., of the University of Pittsburgh School of Pharmacy, with the 2019 Seema S. Sonnad Emerging Leader in Managed Care Research Award during the Patient-Centered Oncology Care® (PCOC) meeting on Friday, Nov. 8

Bio-Path Holdings, Inc., (NASDAQ: BPTH), today announced that it will host a live conference call and audio webcast on Friday, November 15, 2019 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2019 and to provide a business overview

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, reports positive interim data from its open label TACTI-002 Phase II clinical trial, building on the first top line data reported on 26 September 2019.

Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today reported financial results for the third quarter ended September 30, 2019 and provided an overview of the company’s recent progress.